4
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The mannosidoses and ceroid-lipofuscinoses: Experimental studies on two types of storage disease

Pages 51-56 | Accepted 13 Aug 1996, Published online: 06 Jul 2009

References

  • Obituary: George Swanson Christie. Pathology 1980; 13: 786–787, Anonymous
  • Dorling PR. Lysosomal storage diseases in animals. Lysosomes in Biology and Medicine, Dingle JT, Dean RT. Elsevier Science, Amsterdam 1984; 347–379, In
  • Neufeld EF, Lim TW, Shapiro LJ. Inherited disorders of lysosomal metabolism. Annu Rev Biochem 1975; 44: 357–376
  • Neufeld EF. Lysosomal storage diseases. Annu Rev Biochem 1991; 60: 257–280
  • The Metabolic Basis of Metabolic Disease [II]6th ed., CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill, New York 1989; 1565–1839
  • Jolly, RD, Winchester, BG, Gehler, J, et al. Mannosidosis: a comparative review of biochemical and related clinicopathological aspects of three forms of the disease. J Appl Biochem 1981; 3: 273–291
  • Whittem JM, Walker D. Neuronopathy and pseudolipidosis in Aberdeen Angus calves. J Pathol Bacteriol 1957; 74: 281–288
  • Jolly RD. The pathology of the central nervous system in pseudolipidosis of Angus calves. J Pathol 1971; 103: 113–121
  • Hocking JD, Jolly RD, Batt RD. Deficiency of α-mannosidase in Angus cattle. Biochem J 1972; 128: 69–78
  • Phillips NC, Robinson D, Winchester BG, Jolly RD. Mannosidosis in Angus cattle. Biochem J 1974; 137: 363–371
  • Winchester BF, Van de Water NS, Jolly RD. Mannosidosis in Angus cattle. Biochem J 1976; 157: 363–371
  • Phillips NC, Winchester BG, Jolly RD. A serological investigation into the acidic-α-mannosidase in normal Angus cattle and a calf with mannosidosis. Biochem J 1977; 163: 269–277
  • Burditt, LJ, Phillips, NC, Robinson, D, et al. Characterisation of mutant α-mannosidase in bovine mannosidosis. Biochem J 1978; 175: 1013–1022
  • Dorling PR, Huxtable CR, Vogel P. Lysosomal storage in Swainsona spp. toxicosis. An induced mannosidosis. J Neuropathol Appl Neurobiol 1978; 4: 285–291
  • Colgate SM, Dorling PR, Huxtable CR. The isolation and identification of a toxic principle from Swainsona canescens. Plant Toxicology, AA Searight, MP Hegarty, LF James. Queensland Department of Primary Industries, Yeerongpilly 1985; 249–254, In
  • Dorling PR, Huxtable CR, Colgate SM. The pathogenesis of chronic Swainsona sp. toxicity. Plant Toxicology, AA Searight, MP Hegarty, LF James. Queensland Department Primary Industries, Yeerongpilly 1985; 235–265, In
  • Dorling PR, Huxtable CR, Colgate SM. Isolation of swainsonine from Swainsona canescens; Historical aspects. Swainsonine and Related Glycosidase Inhibitors, LF James, AD Elbien, RJ Molyneaux, CD Warren. Iowa State University Press, Ames 1989; 83–90, In
  • Molyneaux RJ, James LF, Panter KB. Chemistry of toxic constituents of locoweed [Astragalus & Oxytropis] species. Plant Toxicology, AA Seawright, MP Hegarty, LF James. Queensland Department of Primary Industries, Yeerongpilly 1985; 266–278, In
  • Elbien AD. The effects of plant indolizidine alkaloids and related compounds on glycoprotein processing. Swainsonine and Related Glycosidase Inhibitors, LF James, AD Elbien, RJ Molyneaux, CD Warren. Iowa State University Press, Ames 1989; 155–187, In
  • Beaudet AL, Thomas GH. Disorders of glycoprotein degradation. The Metabolic Basis of Inherited Disease II, R Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill, New York 1989; 1603–1621, In
  • Healy PJ, Seaman JT, Gardner IA, Sewell CA. β-Mannosidase deficiency in Anglo Nubian goats. Aust Vet J 1981; 57: 504–507
  • Matzura F, Jones MZ, Frazier SE. Structural analysis of the major caprine β-mannosidosis urinary oligosaccharides. Biochim Biophys Acta 1983; 759: 67–73
  • Jolly, RD, Thompson, KG, Bayliss, SL, et al. β-Mannosidosis in a Salers calf. NZ Vet J 1990; 38: 102–105
  • Abbit, MS, Jones, MZ, Kasari, RW, et al. β-Mannosidosis in twelve Salers calves. J Am Vet Med Assoc 1991; 198: 109–113
  • Daniel PF, Warren CD, James LF, Jolly RD. A comparison of swainsonine-induced and genetic α-mannosidosis in Aberdeen Angus cattle. Swainsonine and Related Glycosidase inhibitors, LF James, AD Elbien, RJ Molyneaux, CD Warren. Iowa State University Press, Ames 1989; 331–343, In
  • Jolly RD. Mannosidosis and its control in Angus and Murray Grey cattle. NZ Vet J 1978; 26: 194–198
  • Healy, PJ, Babidge, PJ, Embury, DA, et al. Control of α-mannosidosis in Angus cattle. Aust Vet J 1983; 60: 135–137
  • Jolly RD, Desnick RJ. Inborn errors of lysosomal catabolism: principles of heterozygote detection. Am J Med Genet 1979; 4: 293–307
  • Jolly RD, Healy PJ. Screening for carriers of genetic disease by biochemical means. Vet Rec 1986; 119: 264–267
  • Jolly, RD, Thompson, KG, Murphy, CE, et al. Enzyme replacement therapy: an experiment of nature in a chimeric mannosidosis calf. Pediatr Res 1976; 10: 219–224
  • Walkely, SU, Thrall, MA, Dobrenis, K, et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA 1994; 91: 2970–2974
  • Taylor RM, Farrow BRH, Stewart GJ. Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs. Am J Med Genet 1992; 2: 628–632
  • Grabowski GA, Walling L, Desnick RJ. Human mannosidosis: in vitro and in vivo studies of cofactor supplementation. Enzyme Therapy in Genetic Diseases: 2, RJ Desnick. Alan R Liss, New York 1980; 319–334, In
  • Jolly, RD, Van de Water, NS, Jaanmat, A, et al. Zinc therapy in the bovine mannosidosis model. Enzyme Therapy in Genetic Diseases: 2, RJ Desnick. Alan R Liss, New York 1980; 305–318, In
  • Zeman W. The neuronal ceroid-lipofuscinoses. Progress in Neuropathology, HM Zimmerman, 1976; III: 207–223, In
  • Kohlschutter A, Gardiner RM, Goebel HH. Human forms of neuronal ceroid-lipofuscinosis [Batten disease]: consensus on diagnostic criteria and nomenclature. J Inherit Metab Dis 1993; 16: 241–244
  • Dyken PR. Reconsideration of the classification of the neuronal ceroid-lipofuscinoses. Am J Med Genet 1988, Suppl 5: 59–84
  • Wisniewski KE, Kida E, Patxot OF, Connell F. Variability in the clinical and pathological findings in neuronal ceroid-lipofuscinoses: review of data and observations. Am J Med Genet 1992; 42: 525–532
  • Jolly RD, Palmer DN. Review. The neuronal ceroid-lipofuscinoses [Batten disease]: comparative aspects. Neuropathol Appl Neurobiol 1995; 21: 50–60
  • Jolly, RD, Palmer, DN, Studdert, VP, et al. Canine ceroid-lipofuscinoses: a review and classification. J Small Anim Pract 1994; 35: 299–306
  • Armstrong D, Dimmitt S, van Wormer DE. Studies in Batten disease. 1 Peroxidase deficiency in granulocytes. Arch Neurol 1974; 30: 144–152
  • Jolly RD, Jaanmat A, West DM, Morrison I. Ovine ceroid-lipofuscinosis: a model for Batten's disease. Neuropathol Appl Neurol 1980; 6: 195–209
  • Jolly RD, Jaanmat A, Graydon RJ, Clemett RS. Ceroid-lipofuscinosis: the ovine model. Ceroid-lipofuscinosis [Batten Disease], D Armstrong, N Koppang, J Rider. Elsevier Biomedical Press, Amsterdam 1982; 219–228, In
  • Palmer, DN, Martinus, RD, Cooper, SM, et al. Ovine ceroid-lipofuscinosis: the major lipopigment protein and the lipid-binding subunit of mitochondrial ATP synthase have the same NH2-terminal sequence. J Biol Chem 1989; 264: 5763–5840
  • Fearnley, IM, Walker, JE, Martinus, RD, et al. The sequence of the major protein stored in ovine ceroid-lipofuscinosis is identical with that of the dicyclohexlycarbodimide-reactive proteolipid of mitochondrial ATP synthase. Biochem J 1990; 268: 751–758
  • Palmer, DN, Fearnley, IM, Medd, SM, et al. Lysosomal storage of the DCCD reactive proteolipid subunit of mitochondrial ATP synthase in human and ovine ceroid-lipofuscinosis. Lipofuscin and Ceroid Pigments, EA Porta, 1990; 221–333, In
  • Palmer DN, Fearnley IM, Walker JE. Mitochondrial ATP subunit c storage in the ceroid-lipofuscinoses [Batten Disease]. Am J Med Genet 1992; 42: 561–567
  • Tyynelä J, Palmer DN, Baumann M, Haltia M. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBBS Lett 1993; 330: 8–12
  • Tyynelä, J, Baumann, M, Henseler, M, et al. Sphingolipid activator proteins in the ceroid-lipofuscinoses: an immunological study. Acta Neuropathol [Berlin] 1995; 89: 391–398
  • Moroni-Rawson P, Palmer DN, Jolly RD, Jordan TW. Variant proteins in ovine ceroid-lipofuscinosis. Am J Med Genet 1995; 56: 279–284
  • Jolly, RD, Shimada, A, Craig, AS, et al. Ovine ceroid-lipofuscinosis: pathological changes interpreted in light of biochemical observations. Am J Med Genet 1988, Suppl 5: 159–170
  • Jolly RD. Comparative biology of the ceroid-lipofuscinoses [NCL]: an. overview. Am J Med Genet 1995; 307–311
  • Jolly RD. Batten disease [ceroid-lipofuscinosis]: the enigma of subunit c of mitochondrial ATP synthase accumulation. Neurochem Res 1995; 11: 1301–1304
  • Walkley SU, March PA. Biology of neuronal dysfunction in storage disorders. J Inherit Metab Dis 1993; 16: 284–287
  • Esaki J, Wolfe LS, Ishdoh K, Kominami E. Abnormal degradative pathway of mitochondrial ATP synthase subunit c in late infantile ceroid-lipofuscinosis [Batten] disease. Am J Med Genet 1995; 57: 254–259
  • Folch J, Lees M. Proteolipides: a new type of tissue lipoproteins. Their isolation from brain. J Biol Chem 1951; 191: 807–817
  • Grisola S, Harmandez-Yago J, Knecht E. Regulation of mitochondrial protein concentration: a plausible model which may permit assessing protein turnover. Curr Top Cell Regul 1985; 1031: 71–90
  • Hare JF. Mechanisms of membrane protein turnover. Biochim Biophys Acta 1990; 1031: 71–90
  • International Batten disease consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 1995; 82: 949–957

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.